Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials

<div>Forestplot of two group changes from the baseline in (a) Left ventricular end-diastolic diameter (LVEDD) and (b) Left ventricular end-systolic diameter (LVESD) LVEF.</div>

Cardiovascular Therapeutics

fig5

Figure 5

Figure 5: Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials 